Iovance Biotherapeutics, Inc. (IOVA)
2.52
-0.08
(-3.08%)
USD |
NASDAQ |
Feb 12, 16:00
2.57
+0.05
(+1.98%)
After-Hours: 20:00
Iovance Biotherapeutics Cash from Investing (Quarterly) : 17.01M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Lantheus Holdings, Inc. | -319.47M |
| Plus Therapeutics, Inc. | 1.297M |
| BioStem Technologies, Inc. | -1.168M |
| Protokinetix, Inc. | -0.0056M |
| GB Sciences, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -78.70M |
| Cash from Financing (Quarterly) | 88.06M |
| Free Cash Flow | -351.82M |
| Free Cash Flow Per Share (Quarterly) | -0.246 |
| Free Cash Flow to Equity (Quarterly) | -88.87M |
| Free Cash Flow to Firm (Quarterly) | -89.55M |
| Free Cash Flow Yield | -42.11% |